{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:35:17Z","timestamp":1763037317487,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"am","delay-in-days":404,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.annder.2019.03.006","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T01:56:38Z","timestamp":1561168598000},"page":"440-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Psoriasis\u00a0: \u00e9valuation initiale et bilan th\u00e9rapeutique pratique"],"prefix":"10.1016","volume":"146","author":[{"given":"M.-A.","family":"Richard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2019.03.006_bib0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjd.13343","article-title":"Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris","volume":"17","author":"Gniadecki","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2019.03.006_bib0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/09546634.2016.1177158","article-title":"Review of maintenance of response to psoriasis treatments","volume":"27","author":"Bartos","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2019.03.006_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12039","article-title":"Adherence to medication in patients with psoriasis: a systematic literature review","volume":"168","author":"Thorneloe","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2019.03.006_bib0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jdv.12563","article-title":"Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus","volume":"Suppl. 5","author":"Villani","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.03.006_bib0090","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1468-3083.2010.03600.x","article-title":"Psoriasis: an epidemiological evaluation of disease burden in 590 patients","volume":"24","author":"Meyer","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.03.006_bib0095","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0151-9638(07)78267-4","article-title":"Scores cliniques d\u2019\u00e9valuation de s\u00e9v\u00e9rit\u00e9 du psoriasis","volume":"134","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.03.006_bib0100","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Index of Disease severity (DLQI). A single practical measure for routine clinical use","volume":"3","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2019.03.006_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.annder.2019.03.005","article-title":"Recommandations fran\u00e7aises sur l\u2019utilisation des traitements syst\u00e9miques chez les patients adultes atteints de psoriasis mod\u00e9r\u00e9 \u00e0 s\u00e9v\u00e8re\u00a0: adaptation de l\u2019article original publi\u00e9 dans le JEADV","author":"Amatore","year":"2019","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.03.006_bib0110","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.15340","article-title":"French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults","author":"Amatore","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.03.006_bib0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2019.03.006_bib0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review","volume":"27","author":"Horreau","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.03.006_bib0125","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/jdv.12011","article-title":"Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry","volume":"27","author":"S\u00e1nchez-Moya","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.03.006_bib0065","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2133.2012.11113.x","article-title":"An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial","volume":"167","author":"Bostoen","year":"2012","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963819301346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963819301346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:07:22Z","timestamp":1758971242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963819301346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":13,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0151963819301346"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2019.03.006","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis\u00a0: \u00e9valuation initiale et bilan th\u00e9rapeutique pratique","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2019.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}